Dr. Manesh Dixit

Founder of First Time US Generics, Philadelphia, USA. & First Time US Pharmaceuticals (I) Pvt. Ltd., Navi Mumbai, India.

Qualification :

Dr. Manesh Dixit received his Ph.D. in Pharmaceutics from The Ohio State University in March 1999. He joined The Ohio State University in September 1994 after graduating with a pharmacy degree from the University of Mumbai in India.

Currently, Dr. Dixit is the President and CEO of First Time US Generics LLC., which he founded. USpharma manufactures prescription branded and generic products including transdermal patches and oral solid dosage products for the USA and foreign markets out of its FDA and DEA-audited facilities in Miami, Philadelphia, Kansas City, and Navi Mumbai. In 2017, Dr. Dixit successfully acquired a large-scale commercial operation in Miami, Florida, a 180,000 sq. ft manufacturing facility, along with Nitro-Dur® (Nitroglycerin) Transdermal Infusion System from Merck Sharp & Dohme Corp.

Before starting his business, he was a senior executive with multidisciplinary expertise in the pharmaceutical industry. His expertise included all aspects of pharmaceutical product development, FDA filing, product launch, DEA matters, and day-to-day plant operation. He is well-versed in the intricacies of regulatory strategies as well as in the resolution of patent and exclusivity issues and controlled substance compliance. He also passed the patent bar examination and is registered to practice before the USPTO.